In the most recent quarter (Q3), Better Therapeutics reported EPS of $-0.15, beating estimates of $-0.21 by 0.29%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Better Therapeutics has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Better Therapeutics has averaged an EPS surprise of 0.31% and a revenue surprise of 0.00%.
Analyze the earnings history of Better Therapeutics using advanced sorting and filters.
The chart below shows Better Therapeutics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Better Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Better Therapeutics (BTTX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3.
Better Therapeutics (BTTX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual EPS was $-0.15, which beat the estimate of $-0.21.
Better Therapeutics (BTTX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 9, 2023 for Q3 and the Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-09 | $-0.15 | $-0.21 | 28.6 % |
| Q2 | 2023-08-09 | $-0.24 | $-0.31 | 22.6 % |
| Q1 | 2023-05-11 | $-0.39 | $-0.74 | 47.3 % |
| Q4 | 2023-03-30 | $-0.37 | $-0.51 | 27.5 % |